Altimmune (ALT) Property, Plant & Equipment (Net) (2010 - 2026)

Altimmune (ALT) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn - 642,333.36
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn - 5.32 Mn
3 Akari Therapeutics 1,015.37 Bn 1,015.37 Bn - -
4 BeOne Medicines 471.39 Bn 466.59 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 122.52 Bn 115.28 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 70.33 Bn 61.58 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.74 Bn 62.74 Bn - -
8 Argenx Se 56.10 Bn 50.91 Bn 1.41 Bn 1.96 Bn
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn 518.26 Mn
10 Altimmune 365.92 Mn 365.92 Mn - 208,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 208,000.00
Mar 31, 2026 208,000.00
Dec 31, 2025 312,000.00
Dec 31, 2025 312,000.00
Sep 30, 2025 337,000.00
Sep 30, 2025 337,000.00
Jun 30, 2025 364,000.00
Jun 30, 2025 364,000.00
Mar 31, 2025 384,000.00
Mar 31, 2025 384,000.00
Dec 31, 2024 413,000.00
Dec 31, 2024 413,000.00
Sep 30, 2024 446,000.00
Sep 30, 2024 446,000.00
Jun 30, 2024 483,000.00
Jun 30, 2024 483,000.00
Mar 31, 2024 544,000.00
Mar 31, 2024 544,000.00
Dec 31, 2023 651,000.00
Dec 31, 2023 651,000.00